103 related articles for article (PubMed ID: 11678726)
1. G protein-coupled receptor signalling in in vivo cardiac overload.
Rapacciuolo A; Esposito G; Prasad SV; Rockman HA
Acta Physiol Scand; 2001 Sep; 173(1):51-7. PubMed ID: 11678726
[TBL] [Abstract][Full Text] [Related]
2. Cardiac hypertrophy: role of G protein-coupled receptors.
Esposito G; Rapacciuolo A; Naga Prasad SV; Rockman HA
J Card Fail; 2002 Dec; 8(6 Suppl):S409-14. PubMed ID: 12555153
[TBL] [Abstract][Full Text] [Related]
3. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.
McMullen JR; Jennings GL
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):255-62. PubMed ID: 17324134
[TBL] [Abstract][Full Text] [Related]
4. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch.
Takeishi Y; Huang Q; Abe J; Glassman M; Che W; Lee JD; Kawakatsu H; Lawrence EG; Hoit BD; Berk BC; Walsh RA
J Mol Cell Cardiol; 2001 Sep; 33(9):1637-48. PubMed ID: 11549343
[TBL] [Abstract][Full Text] [Related]
5. Signaling pathways in cardiac myocyte hypertrophy.
Hefti MA; Harder BA; Eppenberger HM; Schaub MC
J Mol Cell Cardiol; 1997 Nov; 29(11):2873-92. PubMed ID: 9405163
[TBL] [Abstract][Full Text] [Related]
6. An "I" on cardiac hypertrophic remodelling: imidazoline receptors and heart disease.
Mukaddam-Daher S
Can J Cardiol; 2012; 28(5):590-8. PubMed ID: 22483786
[TBL] [Abstract][Full Text] [Related]
7. G-proteins in growth and apoptosis: lessons from the heart.
Adams JW; Brown JH
Oncogene; 2001 Mar; 20(13):1626-34. PubMed ID: 11313910
[TBL] [Abstract][Full Text] [Related]
8. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
9. Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.
Oudit GY; Crackower MA; Eriksson U; Sarao R; Kozieradzki I; Sasaki T; Irie-Sasaki J; Gidrewicz D; Rybin VO; Wada T; Steinberg SF; Backx PH; Penninger JM
Circulation; 2003 Oct; 108(17):2147-52. PubMed ID: 12963636
[TBL] [Abstract][Full Text] [Related]
10. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
[TBL] [Abstract][Full Text] [Related]
11. Ginseng (Panax quinquefolius) attenuates leptin-induced cardiac hypertrophy through inhibition of p115Rho guanine nucleotide exchange factor-RhoA/Rho-associated, coiled-coil containing protein kinase-dependent mitogen-activated protein kinase pathway activation.
Moey M; Rajapurohitam V; Zeidan A; Karmazyn M
J Pharmacol Exp Ther; 2011 Dec; 339(3):746-56. PubMed ID: 21875949
[TBL] [Abstract][Full Text] [Related]
12. The Wnt/Frizzled pathway as a therapeutic target for cardiac hypertrophy: where do we stand?
ter Horst P; Smits JF; Blankesteijn WM
Acta Physiol (Oxf); 2012 Jan; 204(1):110-7. PubMed ID: 21624093
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets.
Tham YK; Bernardo BC; Ooi JY; Weeks KL; McMullen JR
Arch Toxicol; 2015 Sep; 89(9):1401-38. PubMed ID: 25708889
[TBL] [Abstract][Full Text] [Related]
14. Genetic factors in cardiac hypertrophy.
Dorn GW; Hahn HS
Ann N Y Acad Sci; 2004 May; 1015():225-37. PubMed ID: 15201163
[TBL] [Abstract][Full Text] [Related]
15. Cardiac regulation by phosphoinositide 3-kinases and PTEN.
Oudit GY; Penninger JM
Cardiovasc Res; 2009 May; 82(2):250-60. PubMed ID: 19147653
[TBL] [Abstract][Full Text] [Related]
16. Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress.
Guo D; Kassiri Z; Basu R; Chow FL; Kandalam V; Damilano F; Liang W; Izumo S; Hirsch E; Penninger JM; Backx PH; Oudit GY
Circ Res; 2010 Nov; 107(10):1275-89. PubMed ID: 20847309
[TBL] [Abstract][Full Text] [Related]
17. Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts.
Booz GW; Baker KM
Cardiovasc Res; 1995 Oct; 30(4):537-43. PubMed ID: 8575002
[TBL] [Abstract][Full Text] [Related]
18. The human angiotensin AT(1) receptor supports G protein-independent extracellular signal-regulated kinase 1/2 activation and cellular proliferation.
Hansen JL; Aplin M; Hansen JT; Christensen GL; Bonde MM; Schneider M; Haunsø S; Schiffer HH; Burstein ES; Weiner DM; Sheikh SP
Eur J Pharmacol; 2008 Aug; 590(1-3):255-63. PubMed ID: 18565507
[TBL] [Abstract][Full Text] [Related]
19. [Cardiac hypertrophy: molecular and cellular events].
Carreño JE; Apablaza F; Ocaranza MP; Jalil JE
Rev Esp Cardiol; 2006 May; 59(5):473-86. PubMed ID: 16750145
[TBL] [Abstract][Full Text] [Related]
20. Small GTP-binding proteins and their regulators in cardiac hypertrophy.
Lezoualc'h F; Métrich M; Hmitou I; Duquesnes N; Morel E
J Mol Cell Cardiol; 2008 Apr; 44(4):623-32. PubMed ID: 18339399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
